CD31 Angiogenesis and Combined Expression of HIF-1α &amp; HIF-2α are Prognostic in Primary Clear-Cell Renal Cell Carcinoma (CC-RCC), but HIFα Transcriptional Products are Not: Implications for Antiangiogenic Trials and HIFα Biomarker Studies in Primary CC-RCC

Dr Swethajit Biswas

CD31 Angiogenesis and Combined Expression of HIF-1α & HIF-2α are Prognostic in Primary Clear-Cell Renal Cell Carcinoma (CC-RCC), but HIFα Transcriptional Products are Not: Implications for Antiangiogenic Trials and HIFα Biomarker Studies in Primary CC-RCC Lookup NU author(s) Dr Swethajit Biswas



Author(s)		Biswas S, Charlesworth P, Turner GDH, Leek R, Thamboo PT, Campo L, Turley H, Dildey P, Protheroe A, Cranston D, Gatter KC, Pezzella F, Harris AL
Publication type		Article
Journal		Carcinogenesis
Year		2012
Volume		33
Issue		9
Pages		1717-1725
ISSN (print)		0143-3334
ISSN (electronic)		1460-2180



Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



Publisher		Oxford University Press
URL		http://dx.doi.org/10.1093/carcin/bgs222
DOI		10.1093/carcin/bgs222

Actions